BERLIN, Germany – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the publication of the IN-TIME study results in the medical journal The Lancet today. 1 The ...

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...

Results from the EVATEL (EVAluation of TELe follow-up) trial are the first in Europe to demonstrate potential safety and efficacy benefits from the remote follow-up of ICD patients. The trial was ...

Please provide your email address to receive an email when new articles are posted on . Remote ICD deactivation for patients receiving hospice care was successful in a small feasibility study.

Dr Melissa Walton-Shirley brings a personal and practice-focused perspective to headlines, research, and overlooked cardiology gems.

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA approved its next-generation Bluetooth-capable implantable cardioverter ...

Sponsors of clinical trials in the United States have a regulatory responsibility under 21 CFR Part 312.50 to monitor the progress of clinical studies. Historically, Sponsors performed in-person ...